Biotechnology
News Category
VERAXA Biotech Receives Positive Regulatory Feedback from Germany for BiTAC®-TCE Program
VERAXA Biotech received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its lead BiTAC®-TCE program, reducing development uncertain...
Onco-Innovations Advances Precision Oncology with ONC010 as Biomarker-Driven Cancer Gains Momentum
Onco-Innovations Ltd. is progressing its lead drug candidate ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligni...
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Cancer Treatment Methods
Lantern Pharma announced a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for its investigational therapy...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform for Solid Tumor Therapies
VERAXA Biotech AG has appointed Christoph Erkel, Ph.D., as chief scientific officer to lead advancement of its proprietary BiTAC platform for developi...
iOrganBio Appoints Stem Cell Expert Lee L. Rubin to Scientific Advisory Board
iOrganBio expands its Scientific Advisory Board with Lee L. Rubin, Ph.D., a leading authority in stem cell biology and regenerative medicine, to advan...
BioAdaptives Completes Commercial Manufacturing for Wellness Product Launch
BioAdaptives has finalized commercial manufacturing and supply chain logistics, enabling the upcoming rollout of its MyndSystem and Xcellara wellness ...
Creative Biolabs Expands Microfluidics Portfolio to Accelerate High-Throughput Antibody Discovery
Creative Biolabs has expanded its integrated microfluidics platform to enhance high-throughput antibody discovery, addressing the growing demand for e...
Quantum BioPharma Targets Multiple Sclerosis and Alcohol Intoxication with Novel Therapies
Quantum BioPharma is advancing a pipeline of treatments for multiple sclerosis and alcohol intoxication, including Lucid-MS for MS and unbuzzd for han...
Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Cancer Therapy Sapu003
Oncotelic Therapeutics announced publication of preclinical data for Sapu003, its intravenous everolimus formulation, supporting its Phase 1 clinical ...
Kairos Pharma and Bayer Collaborate on Combination Therapy for Advanced Prostate Cancer
Kairos Pharma has partnered with Bayer to evaluate its lead antibody ENV-105 in combination with XOFIGO for metastatic castration-resistant prostate c...
VERAXA Biotech Advances BiTAC(R)-TCE Development with Positive Regulatory Feedback from Germany
VERAXA Biotech has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its BiTAC(R)-TCE development strategy, reducing regulat...
VivoSim Labs Raises $4 Million in Private Placement with Healthcare-Focused Institutional Investor
VivoSim Labs secures $4 million through a private placement to fund working capital and general corporate purposes, with warrants exercisable after sh...
Greenwich LifeSciences Advances Phase 3 Trial for Breast Cancer Immunotherapy GLSI-100
Greenwich LifeSciences reports continued progress in its Phase 3 FLAMINGO-01 trial for GLSI-100, with DSMB approval, expanded enrollment to 2,000 pati...
Quantum BioPharma Targets Neurological Disorders with Dual Approach
Quantum BioPharma is developing treatments for multiple sclerosis and alcohol intoxication, addressing significant unmet needs in neurological care.
American Fusion Secures Texas Certificate of Registration for Fusion Engine Testing at Texas Tech
American Fusion Inc. has received a Texas DSHS Certificate of Registration for Industrial Radiation Machines, enabling R&D and testing of its Texatron...
WHO Study Finds No Evidence Linking Mobile Phones to Brain Cancer
A comprehensive World Health Organization review of 13 studies found no evidence that mobile phone use causes brain cancer, potentially alleviating lo...
Quantum BioPharma Reaches Halfway Point in MS Imaging Study, Early Data Shows Promise
Quantum BioPharma announced that its pilot imaging study for multiple sclerosis has enrolled half its patients and preliminary data shows a meaningful...
GeoVax Highlights Strategic Alignment of GEO-MVA With HHS/ASPR's Five-Year Medical Countermeasure Preparedness Strategy
GeoVax Labs announced that its GEO-MVA vaccine platform aligns with the HHS/ASPR's five-year plan for medical countermeasures, emphasizing domestic ma...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech announced it received Scientific Advice from Germany’s Paul-Ehrlich-Institute for its BiTAC-TCE platform, providing clarity on developm...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech announced regulatory feedback from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE cancer therapy, providing clarity on development ...
Regentis Biomaterials Receives Japan Patent Allowance for GelrinC Manufacturing Technology
Regentis Biomaterials received a Japan patent allowance for its organic solvent-free manufacturing process for GelrinC, strengthening its IP portfolio...
MindBio Therapeutics Develops Voice-Based AI for Real-Time Impairment Detection, Targeting Workplace Safety
MindBio Therapeutics is developing an AI-powered voice analysis platform to detect drug and alcohol impairment from short speech samples, offering a n...
Gut Microbiome Metabolites Linked to Improved Immunotherapy Response, Study Finds
A new study reveals that metabolites from gut bacteria may enhance cancer immunotherapy effectiveness, offering potential biomarkers and therapeutic t...
SS Innovations Appoints Sarah M. Romano as CFO Amid Global Robotic Surgery Expansion
SS Innovations International Inc. has appointed veteran medtech finance executive Sarah M. Romano as CFO, bolstering its leadership as it advances U.S...
Creative Biolabs Integrates Microfluidics and Electrochemical Biosensors to Advance Point-of-Care Diagnostics
Creative Biolabs has launched a unified platform combining microfluidics and electrochemical biosensors to enable scalable, high-precision point-of-ca...
BioAdaptives Outlines Xcellara Platform Strategy Ahead of XcellaraHeart Launch
BioAdaptives details its cellular wellness platform strategy, combining a stem cell mobilization base with tissue-specific ingredients, ahead of the A...
NeuroOne Collaborates with Mayo Clinic on Pediatric Brain Cancer Drug Delivery Trial
NeuroOne Medical Technologies announced a collaboration with Mayo Clinic, supported by a Children's Cancer Research Fund grant, to evaluate a novel dr...
Oncotelic Therapeutics Launches AI-Powered Manufacturing Platform to Support Biotech Drug Development
Oncotelic Therapeutics has introduced an AI-driven manufacturing services platform that combines its proprietary PDAOAI architecture with robotics fro...
Quantum BioPharma Advances Multiple Sclerosis Therapy with LUCID-MS Phase 2 Trial on Horizon
Quantum BioPharma progresses its neuroprotective therapy LUCID-MS for multiple sclerosis, targeting myelin repair, with a Phase 2 trial planned after ...
VERAXA Biotech Leverages AI Partnership to Advance BiTAC(R) Oncology Platform
VERAXA Biotech's collaboration with AI research partner Ardigen aims to enhance target discovery and validation for its BiTAC(R) cancer therapy platfo...
Tonix Pharmaceuticals Publishes Mpox Research Supporting TNX-801 Vaccine Development
New preclinical research published in the Journal of Virology by Tonix Pharmaceuticals reveals that the mpox virus clade IIb circulating in the U.S. i...
Nuvectis Pharma Prices $100 Million Public Offering to Fund Pipeline Development
Nuvectis Pharma has priced a $100 million public offering of 5 million shares at $20 per share, with proceeds aimed at advancing its NXP100, NXP200, a...
Kairos Pharma Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma announced favorable interim safety results from its Phase 1 trial of ENV-105 combined with osimertinib for advanced EGFR-mutated NSCLC, ...
NeuroThera Labs Launches Phase IIb Trial for Tourette Syndrome Treatment at Hannover Medical School
NeuroThera Labs has initiated a Phase IIb clinical trial at Hannover Medical School for SCI-110, a cannabinoid-based treatment for Tourette Syndrome, ...
Earth Science Tech Inc. Leverages Telehealth and Peptide Therapies to Strengthen Market Position
Earth Science Tech Inc. is advancing its vertically integrated strategy through proprietary technology and strategic acquisitions, targeting the rapid...
Formycon and OneSource Specialty Pharma Forge Strategic Manufacturing Partnership for Biosimilars
Formycon AG and OneSource Specialty Pharma have announced a strategic partnership to manufacture biosimilars, leveraging OneSource's integrated capabi...
Quantum BioPharma Advances Multiple Sclerosis Therapy LUCID-MS with Phase 2 Trial Planned Following FDA Submission
Quantum BioPharma has submitted an Investigational New Drug application to the FDA for its multiple sclerosis therapy LUCID-MS, which showed favorable...
Quantum BioPharma Advances LUCID-MS Therapy for Multiple Sclerosis into Phase 2 Trials
Quantum BioPharma Ltd. is progressing its proprietary multiple sclerosis therapy, LUCID-MS, into Phase 2 clinical trials after positive Phase 1 safety...
Silo Pharma Subsidiary QwikAgents Joins AMD AI Developer Program
Silo Pharma's subsidiary QwikAgents has been accepted into AMD's AI Developer Program, gaining access to development tools and cloud credits to accele...
VERAXA Biotech Leverages AI Partnership to Advance Cancer Therapy Platform
VERAXA Biotech's collaboration with AI firm Ardigen aims to optimize dual-target combinations for its BiTAC platform, highlighting AI's growing role i...
DN Group AG's Subsidiary Algene Begins Series Production of Microalgae, Completes First Harvest
Algene Holding SE, a subsidiary of DN Group AG, has successfully completed its first harvest of high-purity microalgae, yielding 4,500 liters, and is ...
VERAXA Biotech Partners with Ardigen to Accelerate AI-Driven Cancer Drug Development
VERAXA Biotech has partnered with AI firm Ardigen to apply artificial intelligence to its BiTAC T-cell engager pipeline, aiming to improve target sele...
NanoViricides Receives Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides announced National Ethics Committee approval in the DRC for a Phase II trial of its oral NV-387 gummies against Bundibugyo ebolavirus, o...
Tonix Pharmaceuticals Expands TONMYA Medicare Coverage to Reach 145 Million Lives
Tonix Pharmaceuticals announced a major managed Medicare agreement for TONMYA, expanding pharmacy coverage to approximately 145 million covered lives ...
VERAXA Biotech Partners with Ardigen to Apply AI in Cancer Drug Development
VERAXA Biotech AG (NASDAQ: VRXA) has announced a collaboration with Ardigen S.A. to integrate artificial intelligence into its BiTAC pipeline, aiming ...
Onco-Innovations Completes Reference Standard Program for Lead Oncology Candidate ONC010
Onco-Innovations Limited announced the successful completion of its analytical reference standard preparation program for ONC010, strengthening its CM...
VERAXA Biotech Appoints Carl von Halem as Interim CFO Amid Permanent Search
VERAXA Biotech AG has appointed Carl von Halem as interim chief financial officer, leveraging his experience in corporate finance and life sciences to...
Novel Feeder-Free TIL Expansion Platform Reduces IL-2 Dependence and Enhances Safety in Preclinical Study
Researchers developed a feeder-free TIL expansion protocol that reduces high-dose IL-2 reliance, and combining it with low-dose PD-1 blockade improves...